Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Douglas Fambrough currently holds 231,431 shares of Dicerna Pharmaceuticals Inc (DRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas Fambrough has been a net seller of DRNA stock. They have purchased $488.7K and sold $3.6M worth of shares.
Douglas Fambrough's most recent insider trade was on Dec 28, 2021, when they sold 231,431 shares at $38.25 per share.
Douglas Fambrough serves as Executive at Dicerna Pharmaceuticals Inc (DRNA). They have executed 18 insider transactions totaling $4.1M over their tenure at the company.
Douglas Fambrough holds the position of Executive at Dicerna Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Douglas Fambrough has shown a selling trading pattern, with $488.7K in total purchases and $3.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Douglas Fambrough was on Dec 28, 2021, when they sold $8.9M worth of DRNA shares. This transaction involved 231,431 shares at $38.25 per share.
Douglas Fambrough currently owns 231,431 shares of Dicerna Pharmaceuticals Inc (DRNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Douglas Fambrough's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Douglas Fambrough has 18 Form 4 filings on record as an insider at Dicerna Pharmaceuticals Inc.
Set alerts for Douglas Fambrough and 40,000+ other insiders.